Physician profile
Bing Dai
NPI 1487989711
$2,119.25
in general payments reported to CMS, 2019-2025
7 companies · $1,440 in 2025
The $1,440 reported for 2025 was more than what 97% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $15.87 · 2022: $18.13 · 2023: $122 · 2024: $523 · 2025: $1,440.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,238 · Gift: $648 · Education: $125 · Consulting Fee: $75.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,237.57 |
| Gift | $647.68 |
| Education | $125.00 |
| Consulting Fee | $75.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $1,135.90 | 2022-2025 | Invisalign, Invisalign Go |
| Ultradent Products INC | $638.98 | 2025 | Opalescence |
| Zimvie INC. | $148.72 | 2025 | |
| Dentsply Sirona INC | $101.42 | 2024-2025 | Cerec, Mis |
| Orapharma, A Division of Bausch Health US, LLC | $46.78 | 2021-2024 | Ossix Plus, Arestin |
| Patterson Companies, INC. | $33.26 | 2024-2025 | |
| Biohorizons Implant Systems INC. | $14.19 | 2024 | Biohorizons |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bing Dai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.